• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Influenza Vaccination 2023-2024: ACIP Recommendations and Changes

News
Slideshow

Immunization Awareness Month

Primary care clinicians should take note of small but important changes to the  Advisory Committee on Immunization Practices’ recommendations on annual influenza vaccination for the 2023-2024 respiratory virus season.

One affects administering the flu shot to your patients with egg allergy and the other describes updates to the composition of this season's formulation.

Last year getting a flu shot reduced the risk of being hospitalized for the virus or related complications by 40% to 70%. Get an at-a-glance update here; it's time to start prepping your patients.

Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
©vinnstock/Shutterstock.com

Antivirals for Influenza Underutilized Among Vulnerable Children, Adolescents

Grace Halsey
November 20th 2024
Article

Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Awareness of Lung Cancer Screening Extremely Low Among Those at Highest Risk in the US: New Data /image credit Gerard Silvestri, MD, MS, courtesy of Hollings Cancer Center

Awareness of Lung Cancer Screening Extremely Low Among Those at Highest Risk in the US: New Data

Grace Halsey
November 18th 2024
Article

Among current smokers, 71% had never spoken a clinician about screening and among those who had quit, 75% had never had a conversation.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Sydney Jennings
November 11th 2024
Article

Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

Grace Halsey
November 8th 2024
Article

A decision on ending use of oral phenylephrine as a nasal decongestant in OTC products will be made following public comment on FDA's proposed order.

© 2024 MJH Life Sciences

All rights reserved.